Rani Therapeutics Holdings, Inc.

SEC insider activity covers quarterly filings through June 30, 2026. Later filings are not included. Reported roles do not establish current employment or current holdings. SEC filing documents, sections and filing-text search cover filings dated January 1, 2000 onward. Earlier filings are deferred until after launch.

RANI

organization

SIC: 2834

SEC Insider

$124.7M

270 transactions

Summary

Rani Therapeutics Holdings, Inc. (RANI) is an organization.

Recent Insider Transactions

As filed, including amendments; not net cash flow or current holdings. Joint reports count once. Totals cover known values only.

Buys: $86.1MSales: $38.1M22 insiders

Date	Insider	Type	Value
2025-10-21	South Cone Investments Limited Partnership	Sell	$11.1M
2025-10-20	South Cone Investments Limited Partnership	Sell	$4.6M
2025-10-23	IMRAN MIR A	Buy	$1.3M
2026-06-03	Imran Talat(Chief Executive Officer)	A	$0
2026-06-03	McKinley Kate(Chief Business Officer)	A	$0
2026-06-03	Javadi Alireza(Chief Technical Officer)	A	$0
2026-05-28	IMRAN MIR A	A	$0
2026-05-28	BUTEL JEAN LUC	A	$0
2026-05-28	Ausiello Dennis A	A	$0
2026-05-28	Bassan Abraham	A	$0
2026-05-28	Rometty Lisa Ann	A	$0
2026-05-28	Bailey Vasudev Jaiprakash	A	$0
2025-10-23	IMRAN MIR A	Buy	$0
2025-10-23	Bassan Abraham	A	$0
2025-10-23	Bailey Vasudev Jaiprakash	A	$0
2025-08-01	McKinley Kate(Chief Business Officer)	A	$0
2025-05-28	Farquharson Andrew	A	$0
2025-05-28	Ausiello Dennis A	A	$0
2025-05-28	BUTEL JEAN LUC	A	$0
2025-05-28	Rometty Lisa Ann	A	$0

SEC filings: SEC EDGAR

Activity data: SEC EDGAR

Rani Therapeutics Holdings, Inc. — Contributions, Lobbying & Contracts | Poliscope